Laparoscopic Sleeve Gastrectomy: With or without Duodenal Switch? A Consecutive Series of 800 Cases
Authors:
- S. LebelSLS. Lebel
- S. MarceauSMS. Marceau
- F.S. HouldFHF.S. Hould
- O. LescelleurOLO. Lescelleur
- P. MarceauPMP. Marceau
- S. BironSBS. Biron
- 1 May 2014
- journal article
- research article
- Published by S. Karger AG in Digestive Surgery
- Vol. 31 (1) , 48-54
Abstract
Background: Sleeve gastrectomy (SG) was originally performed as the restrictive and acid-reducing part of a biliopancreatic diversion with duodenal switch (BPD-DS). It is now recognized as a stand-alone procedure, but direct comparison between the two procedures is still lacking. The goal of this study is to compare the outcomes of the two procedures and their respective impact on obesity-related comorbidities. Methods: All patients who had a laparoscopic SG (n = 378) or a laparoscopic BPD-DS (n = 422) before 10/2011 were included in this study (n = 800). Data were obtained from our prospectively maintained electronic database and are reported as mean ± standard deviation comparing SG with BPD-DS patients. Results: SG patients were older (48 ± 11 vs. 40 ± 10 years, p < 0.001) with a higher prevalence of comorbidities (type 2 diabetes mellitus in 51 vs. 37%; hypertension 62 vs. 49%; sleep apnea 63 vs. 51%; all p < 0.001). Initial BMI was 48 ± 9 vs. 48 ± 6 (p = 0.8). There was one 30-day mortality in the BPD-DS group, from a pulmonary embolism, for an overall mortality rate of 0.13%. Thirty-day complications occurred in 6 vs. 8% of patients (p = 0.2), including gastric leaks in 4 (1%) vs. 0 patients (p = 0.049). Mean follow-up was 29 ± 10 months. Excess weight loss was 45 ± 14 vs. 62 ± 15% at 6 months, 53 ± 18 vs. 81 ± 14% at 12 months, 53 ± 23 vs. 87 ± 15% at 18 months, 50 ± 19 vs. 86 ± 15% at 24 months and 51 ± 24 vs. 83 ± 16% at 36 months (p < 0.05 for all time points). The surgery induced the remission of type 2 diabetes mellitus in 56 vs. 90% of patients, hypertension in 54 vs. 76% and sleep apnea in 43 vs. 74% (all p < 0.05). In type 2 diabetic patients, fasting plasma glucose decreased by -1.9 mmol/l after SG vs. -2.9 mmol/l after BPD-DS (p < 0.05) and hemoglobin A1C by -1.1 vs. -1.9% (p < 0.05). Conclusion: SG results in a significant 3-year weight loss and remission of comorbidities. BPD-DS provides further improvement of associated comorbidities and can be an option for the management of insufficient weight loss or residual comorbidities following SG.Keywords
This publication has 11 references indexed in Scilit:
- Metabolic/Bariatric Surgery Worldwide 2011Obesity Surgery, 2013
- Sleeve gastrectomy and type 2 diabetes mellitus: a systematic reviewSurgery for Obesity and Related Diseases, 2010
- Long-term Results of Laparoscopic Sleeve Gastrectomy for ObesityAnnals of Surgery, 2010
- Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive casesSurgical Endoscopy, 2010
- Trends and Stabilization up to 2022 in Overweight and Obesity in Switzerland, Comparison to France, UK, US and AustraliaInternational Journal of Environmental Research and Public Health, 2010
- Sleeve Gastrectomy as Sole and Definitive Bariatric Procedure: 5-Year Results for Weight Loss and GhrelinObesity Surgery, 2010
- Laparoscopic Sleeve Gastrectomy Performed with Intent to Treat Morbid Obesity: A Prospective Single-Center Study of 261 Patients with a Median Follow-up of 1 YearObesity Surgery, 2009
- Prevalence of class I, II and III obesity in CanadaCanadian Medical Association Journal, 2006
- Biliopancreatic Diversion with a Duodenal SwitchObesity Surgery, 1998
- Biliopancreatic Diversion with a New Type of GastrectomyObesity Surgery, 1993